Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CCR5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CCR5 is a gene implicated in neurodegeneration research. Key relationships include: activates, interacts with, therapeutic target. Associated with Als, Cardiovascular, Dementia. Connected to 73 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | CCR5 |
| Aliases | CCR5 chemokine receptor |
| Protein Type | Gene |
| Function | CCR5 is a seven-transmembrane G protein-coupled receptor that binds CCL3 (MIP-1α), CCL4 (MIP-1β), and CCL5 (RANTES). |
| Molecular Weight | 46 kDa |
| Amino Acids | 352 aa |
| Pathways | MAPK, PI3K |
| UniProt ID | P51681 |
| GeneCards | CCR5 |
| Human Protein Atlas | CCR5 |
| N-terminal extracellular domain | Contains glycosylation sites and contributes to ligand binding specificity |
| Extracellular loops (ECL1-3) | Form the ligand-binding pocket for chemokines |
| Transmembrane domains (TM1-7) | Spanning the cell membrane, connecting to intracellular signaling |
| Intracellular loops (ICL1-3) | Couple to G proteins and β-arrestin |
| C-terminal intracellular tail | Contains serine/threonine residues for phosphorylation and regulation |
| Associated Diseases | Als, Alzheimer, Inflammation, Neuroinflammation, Ptsd |
| Interactions | adcy2, ADCY2, AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AND |
| KG Connections | 280 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
CCR5["CCR5"]
PI3K["PI3K"]
CCR5 -->|"activates"| PI3K
Huntington{"Huntington"}
CCR5 -->|"activates"| Huntington
Tauopathy{"Tauopathy"}
CCR5 -->|"activates"| Tauopathy
Neurodegeneration{"Neurodegeneration"}
CCR5 -->|"inhibits"| Neurodegeneration
Dementia{"Dementia"}
CCR5 -->|"interacts with"| Dementia
Als{"Als"}
CCR5 -->|"interacts with"| Als
Ms{"Ms"}
CCR5 -->|"interacts with"| Ms
CCR5 -->|"therapeutic target"| Als
CCR5 -->|"therapeutic target"| Ms
Stroke{"Stroke"}
CCR5 -->|"inhibits"| Stroke
Ischemia{"Ischemia"}
CCR5 -->|"therapeutic target"| Ischemia
Cardiovascular{"Cardiovascular"}
CCR5 -->|"therapeutic target"| Cardiovascular
CCL3["CCL3"]
CCL3 -->|"activates"| CCR5
CCL4["CCL4"]
CCL4 -->|"activates"| CCR5
CCL5["CCL5"]
CCL5 -->|"activates"| CCR5
CCL5 -->|"inhibits"| CCR5
AKT["AKT"]
AKT -->|"activates"| CCR5
PI3K -->|"activates"| CCR5
LC3B["LC3B"]
LC3B -->|"interacts with"| CCR5
FIS1["FIS1"]
FIS1 -->|"interacts with"| CCR5
MFN2["MFN2"]
MFN2 -->|"interacts with"| CCR5
MICROGLIA["MICROGLIA"]
MICROGLIA -->|"therapeutic target"| CCR5
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
NEURODEGENERATIVE_DISEASES -->|"activates"| CCR5
NEURODEGENERATION["NEURODEGENERATION"]
NEURODEGENERATION -->|"inhibits"| CCR5
style CCR5 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| PI3K | activates | gene | 0.90 |
| Mtor | activates | pathway | 0.80 |
| Huntington | activates | disease | 0.75 |
| Tauopathy | activates | disease | 0.75 |
| Autophagy | activates | pathway | 0.70 |
| neurons | expressed_in | cell_type | 0.70 |
| ALS | interacts_with | disease | 0.65 |
| Autoimmune | inhibits | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Traumatic Brain Injury | treats | disease | 0.65 |
| Neurodegeneration | inhibits | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Neuroinflammation | associated_with | disease | 0.65 |
| Neurodegeneration | treats | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Stroke | inhibits | disease | 0.65 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Alzheimer | interacts_with | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Multiple Sclerosis | inhibits | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Autoimmune | activates | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Traumatic Brain Injury | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Metabolic Syndrome | activates | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Dementia | interacts_with | disease | 0.65 |
| Ptsd | associated_with | disease | 0.65 |
| IL-6 | inhibits | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| Innate Immunity | activates | pathway | 0.60 |
| HUNTINGTON'S DISEASE | activates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.60 |
| TAUOPATHY | activates | gene | 0.60 |
| IL-1 | inhibits | gene | 0.60 |
| MICROGLIA | inhibits | gene | 0.60 |
| DIABETES MELLITUS | activates | gene | 0.60 |
| CYTOKINES | inhibits | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CCL5 | activates | gene | 1.00 |
| CCL3 | activates | gene | 0.90 |
| CCL4 | activates | gene | 0.90 |
| MTORC1 | activates | gene | 0.70 |
| TAUOPATHY | activates | gene | 0.70 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| HUNTINGTON | activates | gene | 0.70 |
| MFN2 | interacts_with | gene | 0.60 |
| CCL2 | expressed_in | gene | 0.60 |
| AND | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| FIS1 | interacts_with | gene | 0.60 |
| HDAC3 | inhibits | gene | 0.60 |
| PYROPTOSIS | activates | gene | 0.60 |
| CXCR4 | treats | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| CGAS | therapeutic_target | gene | 0.60 |
| PKC | therapeutic_target | gene | 0.60 |
| REELIN | activates | gene | 0.60 |
| CXCL12 | associated_with | gene | 0.60 |
| ADCY2 | associated_with | gene | 0.60 |
| GRM2 | associated_with | gene | 0.60 |
| NPY | associated_with | gene | 0.60 |
| CXCL8 | associated_with | gene | 0.60 |
| CCR1 | inhibits | gene | 0.60 |
| CXCR3 | inhibits | gene | 0.60 |
| PSD95 | activates | gene | 0.60 |
| CDH23 | associated_with | gene | 0.60 |
| HAPLN1 | associated_with | gene | 0.60 |
| MTNR1A | associated_with | gene | 0.60 |
| C3AR1 | associated_with | gene | 0.60 |
| CCL3 | inhibits | gene | 0.60 |
| TNF | inhibits | gene | 0.60 |
| NLRP3 | inhibits | gene | 0.60 |
| P2RY12 | associated_with | gene | 0.60 |
| CXCL10 | inhibits | gene | 0.60 |
| CCR2 | expressed_in | gene | 0.60 |
| MICROGLIA | therapeutic_target | gene | 0.60 |
| CYTOKINES | therapeutic_target | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| ALZHEIMER | interacts_with | gene | 0.60 |
| NEURODEGENERATION | inhibits | gene | 0.60 |
| CCL5 | inhibits | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| SYNAPTOPHYSIN | treats | gene | 0.60 |
| PSD95 | treats | gene | 0.60 |
| CXCR4 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CCR5 in their description or question text
No additional research found